Biotechnology in Germany industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Germany
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Germany
Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Germany biotechnology market with five year forecasts
Reasons To Buy
What was the size of the Germany biotechnology market by value in 2016?
What will be the size of the Germany biotechnology market in 2021?
What factors are affecting the strength of competition in the Germany biotechnology market?
How has the market performed over the last five years?
What are the main segments that make up Germany's biotechnology market?
The biotechnology market consists of the development, manufacturing, and marketing of products based on advanced biotechnology research. The German biotechnology market is expected to generate total revenues of $8.7bn in 2016, representing a compound annual growth rate (CAGR) of 7% between 2012 and 2016. The Medical/Healthcare segment is expected to be the market's most lucrative in 2016, with total revenues of $4.3bn, equivalent to 49.7% of the market's overall value. There is strong interest in the German biotech industry from foreign players. Japanese Astelles Pharma has entered negotiations to buy Ganymed Pharmaceuticals in order to gain access to the highly regarded cancer antibody technology.